期刊文献+

微粒子酶免疫化学发光法和ELISA定量检测CCP抗体的临床应用评价 被引量:1

Diagnostic Value of Anti-Cyclic Citrulinated Peptide Antibody by Using MEIA and ELISA in Patients with Rheumatoid Arthritis
下载PDF
导出
摘要 目的:应用化学发光法、酶联免疫吸附试验(ELISA)定量检测类风湿性关节炎(RA)患者抗环瓜氨酸多肽(CCP)抗体的含量,探讨CCP抗体在RA早期诊断和治疗中的作用。方法:选取69例RA、30例强直性脊柱炎(AS)、33例干燥综合征(SS)患者、61例健康体检人群,分别用化学发光、ELISA检测其血清CCP抗体的含量。结果:两种方法检测193例样本CCP抗体,阳性结果符合率为98.08%,阴性符合率为100%,总符合率为99.48%,CCP抗体对RA诊断的敏感性、特异性分别为(69.56%,68.11%)、(96.77%,97.26%)、RA患者活动期CCP抗体含量(141.10±93.95)IU/m l与非活动期(45.14±10.54)相比,有显著性差异(P<0.05)。结论:化学发光、ELISA两种方法定量检测CCP抗体的符合率良好,化学发光法适用于仪器自动化,操作简便,易于标准化,可满足临床的需要。CCP抗体是一种新的对RA有较高诊断价值的血清学标志物,有助于对RA病情监测。 Objective To evaluate the sensitivity and specificity of anti-cyclic citrullinated peptide antibody(anti-CCP) in patients with rheumatoid arthritis(RA).Methods Anti-CCP antibodies were examined by using MEIA and ELISA from 69 RA,30 Ankylosingspondylitis(AS),33 Siccasyndrome(SS) and 61 normal donors sera.Results Among 69 patients with RA,The sensitivity and specificity of anti-CCP were(69.56%,68.11%),(96.77%,97.26%) by MEIA and ELISA in RA respectively.The data showed that there was a significant difference between periods of activity and periods of quiescence,However,no difference was found between the results in RA by using MEIA and ELISA.Conclusion Detecting anti-CCP by MEIA may be a brief,standard and reliable method.It might present more sensitive and specific in clinical diagnosis on RA.
出处 《放射免疫学杂志》 CAS 2011年第2期180-182,共3页 Journal of Radioimmanology
关键词 类风湿性关节炎 抗环瓜氨酸多肽抗体 化学发光法 酶联免疫吸附试验 rheumatoid arthritis(RA) anti-cyclic citrullinated peptide antibody(anti-CCP) MEIA ELISA
  • 相关文献

参考文献10

二级参考文献23

共引文献84

同被引文献28

  • 1杭建峰,吴英松,李明.时间分辨荧光免疫分析的研究进展及应用[J].热带医学杂志,2004,4(3):340-343. 被引量:47
  • 2仝文斌,陶其敏.自动化免疫分析的进展[J].中华医学检验杂志,1996,19(6):329-331. 被引量:19
  • 3SCOTT D L, PUGNER K, KAARELA K, et al. The links be- tween joint damage and disability in rheumatoid arthritis [ J ]. Rheumatology (Oxford), 2000, 39(2): 122-132.
  • 4BEJARANO V, QUINN M, CONAGHAN P G, et al. Effect of the early use of the anti - tumor necrosis factor adalimumab on the pre- vention of job loss in patients with early rheumatoid arthritis [ J ]. Arthritis Rheum, 2008, 59(10): 1467-1474.
  • 5~OSSENAAR E R, VAN VENROOIJ W J. Anti - CCP antibod- ies, a highly specific marker for (early) rheumatoid arthritis[ J]. Clin Appl Immun Rev, 2004, 4(4) : 239 -262.
  • 6REPARON SCHUIJT C C, VAN ESCH W J, VAN KOOTEN C, et al. Secretion of anti - citrulline - containing peptide antibody by B lymphocytes in rheumatiod arthritis [ J ]. Arthritis Rheum, 2001, 44(1): 41 -47.
  • 7SCHELLEKENS G A, VISSER H, DE JONG B A, et al. The di- agnosetic properties of rhenmatiod atthritis antibodies recognizing a cyc|ic citrullinated peptide [ J ]. Arthritis Rheum, 2000, 43 ( 1 ) : 155 - 163.
  • 8BIZZARO N, MAZZANTI G, TONUTYI E, et al. Diagnostic ac- curacy of the anti - citrulline antibody assay for rheumatoid arthritis [J]. ClinChem, 2001,47(6): 1089-1093.
  • 9SUZUKI K, SAWADA T, MURAKAMI A, et al. High diagnostic performance of ELISA detection of antibodies to eitrullinated anti- gens in rheumatoid arthritis [ J ]. Scand J Rheumatol, 2003, 32 (4) : 197 -204.
  • 10HAYASHI N, KUMAGAI S. Anti -cyclic citrullinated peptide antibodies and rheumatoid arthritis [ J ]. Rinsho Byori, 2010, 58(5) : 466 - 479.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部